Skip to main content
Top
Published in: Clinical Rheumatology 2/2015

01-02-2015 | Original Article

Single center study on ethnic and clinical features of Behcet’s disease in Moscow, Russia

Authors: Anton Lennikov, Zemfira Alekberova, Regina Goloeva, Nobuyoshi Kitaichi, Lev Denisov, Kenichi Namba, Mitsuhiro Takeno, Yoshiaki Ishigatsubo, Nobuhisa Mizuki, Eugeny Nasonov, Susumu Ishida, Shigeaki Ohno

Published in: Clinical Rheumatology | Issue 2/2015

Login to get access

Abstract

For the purpose of investigating Behcet’s disease (BD) in Russia, 250 consecutive patients (177 men and 73 women) diagnosed with BD between 1990 and 2010 at the Research Institute of Rheumatology, Russian Academy of Medical Sciences in Moscow were enrolled in this study. The ethnic backgrounds of the patients were reported as follows: 23.2 % (58 cases) from Russia, 12.8 % (32 cases) from Azerbaijan, 14.4 % (36 cases) from Armenia, 8.8 % (22 cases) from Chechnya, and 21.6 % (55 cases) from Dagestan. The remaining 19.2 % (48 cases) were from other regions or of unknown origin. More than half (57.6 %) of the Behcet’s disease patients originated from Central Asia, specifically Azerbaijan, Armenia, Chechnya, and Dagestan. The mean age at disease onset was 31.5 ± 9.38 (13–60) years old, and the most typical initial manifestations were oral aphthous ulcers. Patients aged 20–39 years old were more commonly affected and displayed a wide clinical spectrum of the disease, with varieties of severe internal organ involvement. The manifestations observed throughout the course of the disease included oral aphthous ulcers (100 %), various cutaneous lesions (88.8 %), genital ulcers (81.2 %), and ocular lesions (54.0 %). Besides these, many organs/systems were implicated in patient cases, namely joint (53.2 %), vascular (25.2 %), neurological (8.0 %), gastrointestinal (25.2 %), and cardiac (5.6 %) systems. Involvements of ocular (p < 0.01) and skin (p < 0.01) lesions were more frequent in men than in women. HLA-B51 and HLA-A26 typing was performed in 127 patients and 508 healthy controls. HLA-B51 was found in 63.0 % of BD patients compared to 20.7 % of the healthy control subjects (p < 0.001), and HLA-A26 was present in 11.3 % of BD patients and 18.9 % of the control group. This study shows the presence of BD in Russia, and it is suggested that its prevalence in Central Asian people is much higher than that in White Russian.
Literature
1.
go back to reference International Study Group for Behcet’s disease (1990) Criteria for diagnosis of Behcet’s disease. Lancet 335(8697):1078-80 International Study Group for Behcet’s disease (1990) Criteria for diagnosis of Behcet’s disease. Lancet 335(8697):1078-80
2.
go back to reference Azizlerli G, Kose AA, Sarica R, Gul A, Tutkun IT, Kulac M et al (2003) Prevalence of Behcet’s disease in Istanbul, Turkey. Int J Dermatol 42(10):803–806PubMedCrossRef Azizlerli G, Kose AA, Sarica R, Gul A, Tutkun IT, Kulac M et al (2003) Prevalence of Behcet’s disease in Istanbul, Turkey. Int J Dermatol 42(10):803–806PubMedCrossRef
3.
go back to reference Bang D, Yoon KH, Chung HG, Choi EH, Lee ES, Lee S (1997) Epidemiological and clinical features of Behcet’s disease in Korea. Yonsei Med J 38(6):428–436PubMedCrossRef Bang D, Yoon KH, Chung HG, Choi EH, Lee ES, Lee S (1997) Epidemiological and clinical features of Behcet’s disease in Korea. Yonsei Med J 38(6):428–436PubMedCrossRef
4.
go back to reference Barkhudaryan S (1969) The Armenian-Caucasian Albanian Kingdom of Derbend. Patma-Banasirakan Handes 3:125–147 Barkhudaryan S (1969) The Armenian-Caucasian Albanian Kingdom of Derbend. Patma-Banasirakan Handes 3:125–147
5.
go back to reference Davatchi F, Shahram F, Chams-Davatchi C, Shams H, Nadji A, Akhlaghi M et al (2010) Behcet’s disease in Iran: analysis of 6500 cases. Int J Rheum Dis 13(4):367–373PubMedCrossRef Davatchi F, Shahram F, Chams-Davatchi C, Shams H, Nadji A, Akhlaghi M et al (2010) Behcet’s disease in Iran: analysis of 6500 cases. Int J Rheum Dis 13(4):367–373PubMedCrossRef
6.
go back to reference El Menyawi MM, Raslan HM, Edrees A (2009) Clinical features of Behcet’s disease in Egypt. Rheumatol Int 29(6):641–646PubMedCrossRef El Menyawi MM, Raslan HM, Edrees A (2009) Clinical features of Behcet’s disease in Egypt. Rheumatol Int 29(6):641–646PubMedCrossRef
7.
go back to reference Horie Y, Meguro A, Kitaichi N, Lee EB, Kanda A, Noda K et al (2012) Replication of a microsatellite genome-wide association study of Behcet’s disease in a Korean population. Rheumatology (Oxford) 51(6):983–986CrossRef Horie Y, Meguro A, Kitaichi N, Lee EB, Kanda A, Noda K et al (2012) Replication of a microsatellite genome-wide association study of Behcet’s disease in a Korean population. Rheumatology (Oxford) 51(6):983–986CrossRef
8.
go back to reference Horie Y, Meguro A, Ota M, Kitaichi N, Katsuyama Y, Takemoto Y et al (2009) Association of TLR4 polymorphisms with Behcet’s disease in a Korean population. Rheumatology (Oxford) 48(6):638–642CrossRef Horie Y, Meguro A, Ota M, Kitaichi N, Katsuyama Y, Takemoto Y et al (2009) Association of TLR4 polymorphisms with Behcet’s disease in a Korean population. Rheumatology (Oxford) 48(6):638–642CrossRef
9.
go back to reference Ideguchi H, Suda A, Takeno M, Ueda A, Ohno S, Ishigatsubo Y (2011) Behcet disease: evolution of clinical manifestations. Medicine (Baltimore) 90(2):125–132CrossRef Ideguchi H, Suda A, Takeno M, Ueda A, Ohno S, Ishigatsubo Y (2011) Behcet disease: evolution of clinical manifestations. Medicine (Baltimore) 90(2):125–132CrossRef
10.
go back to reference Kaneko F, Nakamura K, Sato M, Tojo M, Zheng X, Zhang JZ (2003) Epidemiology of Behcet’s disease in Asian countries and Japan. Adv Exp Med Biol 528:25–29PubMedCrossRef Kaneko F, Nakamura K, Sato M, Tojo M, Zheng X, Zhang JZ (2003) Epidemiology of Behcet’s disease in Asian countries and Japan. Adv Exp Med Biol 528:25–29PubMedCrossRef
12.
go back to reference Kaya TI, Dur H, Tursen U, Gurler A (2002) Association of class I HLA antigens with the clinical manifestations of Turkish patients with Behcet’s disease. Clin Exp Dermatol 27(6):498–501PubMedCrossRef Kaya TI, Dur H, Tursen U, Gurler A (2002) Association of class I HLA antigens with the clinical manifestations of Turkish patients with Behcet’s disease. Clin Exp Dermatol 27(6):498–501PubMedCrossRef
13.
go back to reference Kitaichi N, Miyazaki A, Iwata D, Ohno S, Stanford MR, Chams H (2007) Ocular features of Behcet’s disease: an international collaborative study. Br J Ophthalmol 91(12):1579–1582PubMedCentralPubMedCrossRef Kitaichi N, Miyazaki A, Iwata D, Ohno S, Stanford MR, Chams H (2007) Ocular features of Behcet’s disease: an international collaborative study. Br J Ophthalmol 91(12):1579–1582PubMedCentralPubMedCrossRef
14.
go back to reference Kitaichi N, Miyazaki A, Stanford MR, Iwata D, Chams H, Ohno S (2009) Low prevalence of juvenile-onset Behcet’s disease with uveitis in East/South Asian people. Br J Ophthalmol 93(11):1428–1430PubMedCrossRef Kitaichi N, Miyazaki A, Stanford MR, Iwata D, Chams H, Ohno S (2009) Low prevalence of juvenile-onset Behcet’s disease with uveitis in East/South Asian people. Br J Ophthalmol 93(11):1428–1430PubMedCrossRef
15.
go back to reference Krause I, Molad Y, Weinberger A (1999) Association of HLA-B5 with clinical expression and severity of Behcet’s disease in Israel. J Clin Rheumatol 5(3):137–140PubMedCrossRef Krause I, Molad Y, Weinberger A (1999) Association of HLA-B5 with clinical expression and severity of Behcet’s disease in Israel. J Clin Rheumatol 5(3):137–140PubMedCrossRef
16.
go back to reference Meguro A, Inoko H, Ota M, Katsuyama Y, Oka A, Okada E et al (2010) Genetics of Behcet disease inside and outside the MHC. Ann Rheum Dis 69(4):747–754PubMedCrossRef Meguro A, Inoko H, Ota M, Katsuyama Y, Oka A, Okada E et al (2010) Genetics of Behcet disease inside and outside the MHC. Ann Rheum Dis 69(4):747–754PubMedCrossRef
17.
go back to reference Mizuki N, Meguro A, Ota M, Ohno S, Shiota T, Kawagoe T et al (2010) Genome-wide association studies identify IL23R-IL12RB2 and IL10 as Behcet’s disease susceptibility loci. Nat Genet 42(8):703–706PubMedCrossRef Mizuki N, Meguro A, Ota M, Ohno S, Shiota T, Kawagoe T et al (2010) Genome-wide association studies identify IL23R-IL12RB2 and IL10 as Behcet’s disease susceptibility loci. Nat Genet 42(8):703–706PubMedCrossRef
18.
go back to reference Neves FS, Caldas CA, Lage LV, Goldenstein-Schainberg C, Goncalves CR (2009) Faraway from the silk route: demographic and clinical features of Behcet’s disease in 106 Brazilian patients. Clin Rheumatol 28(5):543–546PubMedCrossRef Neves FS, Caldas CA, Lage LV, Goldenstein-Schainberg C, Goncalves CR (2009) Faraway from the silk route: demographic and clinical features of Behcet’s disease in 106 Brazilian patients. Clin Rheumatol 28(5):543–546PubMedCrossRef
19.
go back to reference Ohno S, Aoki K, Sugiura S, Nakayama E, Itakura K (1973) Letter: HL-A5 and Behcet’s disease. Lancet 2(7842):1383–1384CrossRef Ohno S, Aoki K, Sugiura S, Nakayama E, Itakura K (1973) Letter: HL-A5 and Behcet’s disease. Lancet 2(7842):1383–1384CrossRef
20.
go back to reference Ohno S, Ohguchi M, Hirose S, Matsuda H, Wakisaka A, Aizawa M (1982) Close association of HLA-Bw51 with Behcet’s disease. Arch Ophthalmol 100(9):1455–1458PubMedCrossRef Ohno S, Ohguchi M, Hirose S, Matsuda H, Wakisaka A, Aizawa M (1982) Close association of HLA-Bw51 with Behcet’s disease. Arch Ophthalmol 100(9):1455–1458PubMedCrossRef
21.
go back to reference Remmers EF, Cosan F, Kirino Y, Ombrello MJ, Abaci N, Satorius C et al (2010) Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Behcet’s disease. Nat Genet 42(8):698–702PubMedCentralPubMedCrossRef Remmers EF, Cosan F, Kirino Y, Ombrello MJ, Abaci N, Satorius C et al (2010) Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Behcet’s disease. Nat Genet 42(8):698–702PubMedCentralPubMedCrossRef
22.
go back to reference Sachetto Z, Mahayri N, Ferraz RH, Costallat LT, Bertolo MB (2011) Behcet’s disease in Brazilian patients: demographic and clinical features. Rheumatol Int 32(7):2063–2067PubMedCrossRef Sachetto Z, Mahayri N, Ferraz RH, Costallat LT, Bertolo MB (2011) Behcet’s disease in Brazilian patients: demographic and clinical features. Rheumatol Int 32(7):2063–2067PubMedCrossRef
23.
24.
go back to reference Verity DH, Marr JE, Ohno S, Wallace GR, Stanford MR (1999) Behcet’s disease, the Silk Road and HLA-B51: historical and geographical perspectives. Tissue Antigens 54(3):213–220PubMedCrossRef Verity DH, Marr JE, Ohno S, Wallace GR, Stanford MR (1999) Behcet’s disease, the Silk Road and HLA-B51: historical and geographical perspectives. Tissue Antigens 54(3):213–220PubMedCrossRef
25.
go back to reference Zhang Z, He F, Shi Y (2012) Behcet’s disease seen in China: analysis of 334 cases. Rheumatol Int 33(3):645–648PubMedCrossRef Zhang Z, He F, Shi Y (2012) Behcet’s disease seen in China: analysis of 334 cases. Rheumatol Int 33(3):645–648PubMedCrossRef
Metadata
Title
Single center study on ethnic and clinical features of Behcet’s disease in Moscow, Russia
Authors
Anton Lennikov
Zemfira Alekberova
Regina Goloeva
Nobuyoshi Kitaichi
Lev Denisov
Kenichi Namba
Mitsuhiro Takeno
Yoshiaki Ishigatsubo
Nobuhisa Mizuki
Eugeny Nasonov
Susumu Ishida
Shigeaki Ohno
Publication date
01-02-2015
Publisher
Springer London
Published in
Clinical Rheumatology / Issue 2/2015
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-013-2442-9

Other articles of this Issue 2/2015

Clinical Rheumatology 2/2015 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.